camptothecin has been researched along with Androgen-Independent Prostatic Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilusic, M; Chau, CH; Cordes, LM; Dahut, WL; Figg, WD; Gulley, JL; Huitema, ADR; Karzai, F; Madan, RA; Peer, CJ; Schellens, JHM; Schmidt, KT; Wroblewski, S | 1 |
| Figg, WD; Huitema, ADR; Madan, RA; Peer, CJ; Schellens, JHM; Schmidt, KT; Williams, MD; Wroblewski, S | 1 |
| Gao, YR; Jia, TT; Liu, L; Pan, G; Wang, W; Yuan, X; Yuan, Y; Zeng, HR; Zhang, D | 1 |
| Fu, P; Imperato-McGinley, J; Tang, Z; Wang, G; Wang, L; Wang, X; Yu, R; Zhao, Y; Zhu, YS | 1 |
2 trial(s) available for camptothecin and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide.
Topics: Camptothecin; Cyclodextrins; Cystitis; Humans; Male; Nanoparticles; Nitriles; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome | 2022 |
Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Camptothecin; Cyclodextrins; Drug Interactions; Drug Stability; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant | 2020 |
2 other study(ies) available for camptothecin and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Development of (G3-C12)-mediated camptothecin polymeric prodrug targeting to Galectin-3 receptor against androgen-independent prostate cancer.
Topics: Animals; Blood Proteins; Camptothecin; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Development; Galectins; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Polymers; Prodrugs; Prostatic Neoplasms, Castration-Resistant; Xenograft Model Antitumor Assays | 2020 |
Dissociation of NSC606985 induces atypical ER-stress and cell death in prostate cancer cells.
Topics: Apoptosis; Butylamines; Camptothecin; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Protease Inhibitors; Taurochenodeoxycholic Acid | 2016 |